Combining antiviral drugs with BET inhibitors is beneficial in combatting SARS‐CoV‐2 infection
Abstract The COVID‐19 pandemic caused by the novel coronavirus SARS‐CoV‐2 has resulted in more than 500 million cases and 6 million deaths. Several antiviral therapies and vaccines have been developed to mitigate the spread of this infection. However, new approaches are required to battle emerging S...
Main Authors: | Arpan Acharya, Tatiana G. Kutateladze, Siddappa N. Byrareddy |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | Clinical and Translational Discovery |
Subjects: | |
Online Access: | https://doi.org/10.1002/ctd2.66 |
Similar Items
-
Hedging on Betting Markets
by: Gustav Axén, et al.
Published: (2020-08-01) -
Home bias in sport betting: Evidence from Czech betting market
by: Rostislav Staněk
Published: (2017-03-01) -
Home bias in sport
betting: Evidence from Czech betting market
by: Rostislav Staněk
Published: (2017-03-01) -
Determinants of problem sports betting among college students: moderating roles of betting frequency and impulsive betting tendency
by: Yawen Shen
Published: (2023-10-01) -
Relevance of BET Family Proteins in SARS-CoV-2 Infection
by: Nieves Lara-Ureña, et al.
Published: (2021-07-01)